Riskpilot← Back to searchSign inGet full accessBIOCOTECH AS
ASActiveOrg 992235934Gamlehaugvegen 20, 5230 ParadisOther manufacturing n.e.c. · NACE 3299Est. 20081 employeeswww.biocotech.no
Revenue 2024
NOK 8,9M
+101% vs 2023
EBITDA margin
11.2%
+130% vs 2023
Equity ratio
57.8%
Financial strength
Net profit 2024
NOK 764K
+129% vs 2023
| Revenue | NOK 8,9M | +101% |
| EBITDA | NOK 993K | +130% |
| Net profit | NOK 764K | +129% |
| Total assets | NOK 17M | +4% |
| Equity | NOK 9,8M | +8% |
| Employees | 1 | — |
Legal name
BIOCOTECH AS
Org number
992235934
Legal form
Aksjeselskap
NACE code
3299 · Other manufacturing n.e.c.
Founded
26. januar 2008
Share capital
NOK 333 300
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Utvikling og salg av avfallshåndteringsutstyr og aktiviteter som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet.
Address
Gamlehaugvegen 20, 5230 Paradis
Website
www.biocotech.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 281 | 2 598 | 4 510 | 4 421 | 8 895 |
| Staff expenses | −472 | −772 | −637 | −569 | −570 |
| EBITDA | −354 | −353 | 1 345 | −3 320 | 993 |
| Depreciation & amort. | −1 078 | −32 | −60 | −126 | −147 |
| EBIT | −1 432 | −385 | 1 285 | −3 446 | 847 |
| Net financials | −194 | 33 | −81 | −99 | 115 |
| Profit before tax | −1 626 | −351 | 1 203 | −3 545 | 962 |
| Tax | −269 | −12 | 637 | −928 | 198 |
| Net profit | −1 357 | −340 | 567 | −2 617 | 764 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 404 | 13 269 | 19 861 | 16 317 | 16 970 |
| Equity | 11 150 | 11 100 | 11 667 | 9 050 | 9 814 |
| Long-term debt | 0 | 0 | 0 | 1 000 | 800 |
| Short-term debt | 1 254 | 2 169 | 8 194 | 6 267 | 6 356 |
| Total debt | 1 254 | 2 169 | 8 194 | 7 267 | 7 156 |
EBITDA margin
11.2%
This company
15.8%
Market median
-29% vs market
20202024
Equity ratio
57.8%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
7.8%
This company
18.4%
Market median
-58% vs market
20202024
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20202024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20202024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TH Chief Executive Officer | Chief Executive Officer | 2009 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (1) | ||
| Board of Directors | 2020 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fav Gruppen As
BIOCOTECH AS Board members of BIOCOTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tarje Hope Veidung | Chief Executive Officer | 0 companies |
| Arne Veidung | Board of Directors | 0 companies |
| Haakon Jard Veidung | Chairman | 0 companies |